<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
71753-1450-1
</NDCCode>
<PackageDescription>
30 mL in 1 BOTTLE, SPRAY (71753-1450-1)
</PackageDescription>
<NDC11Code>
71753-1450-01
</NDC11Code>
<ProductNDC>
71753-1450
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Influenzinum
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Influenzinum (2020-2021)
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20201109
</StartMarketingDate>
<EndMarketingDate>
20251125
</EndMarketingDate>
<MarketingCategoryName>
UNAPPROVED HOMEOPATHIC
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Ratis, LLC
</LabelerName>
<SubstanceName>
INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)
</SubstanceName>
<StrengthNumber>
10; 10; 10; 10
</StrengthNumber>
<StrengthUnit>
[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2025-11-25
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20201109
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20251125
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>